Incannex Healthcare (IXHL) Competitors $2.59 +0.32 (+14.10%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends IXHL vs. TRDA, VECT, QTTB, ALMS, ORIC, NUVB, SLN, AURA, CRVS, and LRMRShould you be buying Incannex Healthcare stock or one of its competitors? The main competitors of Incannex Healthcare include Entrada Therapeutics (TRDA), VectivBio (VECT), Q32 Bio (QTTB), Alumis (ALMS), ORIC Pharmaceuticals (ORIC), Nuvation Bio (NUVB), Silence Therapeutics (SLN), Aura Biosciences (AURA), Corvus Pharmaceuticals (CRVS), and Larimar Therapeutics (LRMR). These companies are all part of the "pharmaceutical products" industry. Incannex Healthcare vs. Entrada Therapeutics VectivBio Q32 Bio Alumis ORIC Pharmaceuticals Nuvation Bio Silence Therapeutics Aura Biosciences Corvus Pharmaceuticals Larimar Therapeutics Incannex Healthcare (NASDAQ:IXHL) and Entrada Therapeutics (NASDAQ:TRDA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, community ranking, risk, media sentiment, profitability, dividends, earnings and analyst recommendations. Which has higher valuation and earnings, IXHL or TRDA? Entrada Therapeutics has higher revenue and earnings than Incannex Healthcare. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIncannex Healthcare$10K16,441.32-$18.46MN/AN/AEntrada Therapeutics$129.01M5.07-$6.68M$2.965.95 Do analysts prefer IXHL or TRDA? Entrada Therapeutics has a consensus target price of $21.50, indicating a potential upside of 22.16%. Given Entrada Therapeutics' higher probable upside, analysts clearly believe Entrada Therapeutics is more favorable than Incannex Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Incannex Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AEntrada Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is IXHL or TRDA more profitable? Entrada Therapeutics has a net margin of 43.63% compared to Incannex Healthcare's net margin of 0.00%. Entrada Therapeutics' return on equity of 35.16% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Incannex HealthcareN/A N/A N/A Entrada Therapeutics 43.63%35.16%20.41% Do insiders & institutionals have more ownership in IXHL or TRDA? 0.4% of Incannex Healthcare shares are held by institutional investors. Comparatively, 86.4% of Entrada Therapeutics shares are held by institutional investors. 14.6% of Incannex Healthcare shares are held by company insiders. Comparatively, 7.6% of Entrada Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor IXHL or TRDA? In the previous week, Incannex Healthcare and Incannex Healthcare both had 1 articles in the media. Entrada Therapeutics' average media sentiment score of 1.46 beat Incannex Healthcare's score of 0.76 indicating that Entrada Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Incannex Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Entrada Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor IXHL or TRDA? Entrada Therapeutics received 14 more outperform votes than Incannex Healthcare when rated by MarketBeat users. CompanyUnderperformOutperformIncannex HealthcareN/AN/AEntrada TherapeuticsOutperform Votes1477.78% Underperform Votes422.22% Which has more volatility and risk, IXHL or TRDA? Incannex Healthcare has a beta of 8.15, meaning that its share price is 715% more volatile than the S&P 500. Comparatively, Entrada Therapeutics has a beta of -0.26, meaning that its share price is 126% less volatile than the S&P 500. SummaryEntrada Therapeutics beats Incannex Healthcare on 10 of the 13 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXHL vs. The Competition Export to ExcelMetricIncannex HealthcarePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$164.41M$7.03B$5.40B$8.53BDividend YieldN/A7.96%5.13%4.14%P/E RatioN/A9.93115.5615.18Price / Sales16,441.32381.421,484.3492.77Price / CashN/A47.3439.6634.07Price / Book14.395.324.665.02Net Income-$18.46M$153.56M$119.06M$225.46M7 Day Performance14.60%0.11%0.80%0.37%1 Month Performance59.88%15.22%5.65%3.57%1 Year Performance142.06%41.14%36.76%29.44% Incannex Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXHLIncannex Healthcare0.9939 of 5 stars$2.59+14.1%N/A+148.8%$164.41M$10,000.000.003Gap UpTRDAEntrada Therapeutics2.4135 of 5 stars$16.99+0.9%$21.50+26.5%+13.5%$573.57M$239.40M5.74110Upcoming EarningsPositive NewsVECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030High Trading VolumeQTTBQ32 Bio1.9454 of 5 stars$50.59+6.2%$72.33+43.0%N/A$563.19M$1.16M-2.2039News CoverageALMSAlumisN/A$11.90-0.6%$28.00+135.3%N/A$554.89MN/A0.00N/AAnalyst ForecastNews CoverageORICORIC Pharmaceuticals4.2103 of 5 stars$8.15-3.4%$18.00+120.9%+43.2%$549.49MN/A-4.6680Upcoming EarningsAnalyst ForecastNews CoverageNUVBNuvation Bio3.8174 of 5 stars$2.21-3.9%$6.40+189.6%+98.3%$546.25M$1.44M-1.0560Upcoming EarningsSLNSilence Therapeutics2.7473 of 5 stars$18.08+0.6%$57.20+216.4%+104.2%$541.10M$17.90M-14.82100AURAAura Biosciences3.9407 of 5 stars$10.92-2.8%$23.00+110.6%+13.2%$541.01MN/A-6.1050Short Interest ↓CRVSCorvus Pharmaceuticals1.5784 of 5 stars$8.31+8.2%$10.83+30.4%+671.2%$519.80MN/A-18.4730Upcoming EarningsAnalyst DowngradeShort Interest ↑High Trading VolumeLRMRLarimar Therapeutics2.8618 of 5 stars$8.01+0.6%$20.43+155.0%+169.7%$511.05MN/A-7.1530Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage Related Companies and Tools Related Companies Entrada Therapeutics Alternatives VectivBio Alternatives Q32 Bio Alternatives Alumis Alternatives ORIC Pharmaceuticals Alternatives Nuvation Bio Alternatives Silence Therapeutics Alternatives Aura Biosciences Alternatives Corvus Pharmaceuticals Alternatives Larimar Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IXHL) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
